ArisGlobal Achieves Landmark Client Growth and Innovative Breakthroughs for 2024

ArisGlobal's Landmark Growth in 2024



ArisGlobal, a pioneering technology firm in the life sciences sector and the creator of LifeSphere®, has declared 2024 as a transformative year defined by extraordinary growth and innovation. With a notable surge in clients and record global deployments, ArisGlobal is setting new benchmarks in the industry.

Significant Client Expansion


The company reported a substantial increase in its client base throughout 2024. Key highlights include:
  • - 11 new life sciences clients acquired between January and December.
  • - A total of 91 clients expanded their operations, showcasing the ongoing success of LifeSphere solutions.
  • - A notable 40% annual growth in client acquisition within the Asia-Pacific region reflects ArisGlobal’s expanding footprint in vital markets.

To foster these relationships further, ArisGlobal launched the Most Valued Customer program, aimed at deepening engagement with strategically critical clients. Participants in this program gain exclusive benefits, including premium support, early access to new features, active participation in product innovation, and invitations to ArisGlobal industry events.

Steve Nuckols, Chief Customer Officer, noted that the company's growth symbolizes the tangible return on investment provided through its solutions. By actively listening to clients and perpetually refining its offerings, ArisGlobal enhances customer satisfaction and drives innovation.

Impressive Global Deployments


ArisGlobal has exhibited remarkable capabilities in planning, implementing, and deploying cloud-based solutions across the globe. The company reported a 23% increase in total deployments of the LifeSphere platform compared to the prior year, with:
  • - 57 total deployments concerning safety and regulatory frameworks.
  • - 14 deployments in the APAC region, representing a 40% year-over-year growth.
  • - Successful implementations for three of the world’s ten largest pharmaceutical companies have solidified ArisGlobal as a trusted partner in the sector.

Raj Hattarki, Chief Operating Officer, emphasized that the company’s end-to-end support before, during, and after deployments is crucial to its successes, further strengthening the trust clients have in their solutions.

Unprecedented Product Innovations


In 2024, ArisGlobal invested heavily in product innovations, successfully launching LifeSphere NavaX, a next-generation cognitive computing engine meant to expedite research and development through advanced technologies like Large Language Models (LLMs) and Generative AI (GenAI). Key enhancements include:
  • - Advanced Intake, a leading industry solution that automates safety data collection, revolutionizing traditional adverse event case collection with dynamic data extraction technologies.
  • - Advanced Signals, which promises unparalleled speed and accuracy in signal detection, enabling proactive safety issue management.
  • - Literature Intelligence, streamlining the assessment of safety documents through dynamic data extraction and workflow automation.
  • - Health Authority Interactions, enhancing regulatory teams’ speed and precision in responding to health authority communications, thus improving decision quality and compliance.

Four global pharmaceutical companies have already adopted LifeSphere NavaX, confirming its impact on streamlining processes in safety, regulation, and medical affairs.

Additionally, ArisGlobal introduced the Generation AI Council and CXO Connect forums in early 2024 to facilitate collaborations among industry executives, stimulating practical discussions on implementing Generative AI in life sciences.

Looking Ahead


The achievements underscored by ArisGlobal in 2024 lay a robust foundation for continued growth and innovation in 2025. The company remains dedicated to empowering life sciences organizations with solutions that drive efficiency, regulatory compliance, and improved patient outcomes.

Aman Wasan, CEO of ArisGlobal, expressed a commitment to tackle industry challenges, such as escalating R&D costs and outdated workflows, through effective utilization of technology with LifeSphere NavaX. He emphasized that future endeavors would focus on advancing initiatives that empower clients and transform the landscape of life sciences.

About ArisGlobal


Headquartered in the United States with regional offices in Europe, India, Japan, and China, ArisGlobal is at the forefront of life sciences technology, facilitating breakthroughs and efficient pathways for new products to market. For more insights and updates, follow them on LinkedIn or visit their official website at arisglobal.com.

Topics Business Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.